Role of Repeat18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma
Author(s) -
Moshim Kukar,
Raed Alnaji,
Feraas Jabi,
Timothy A. Platz,
Kristopher Attwood,
Hector Nava,
Kfır Ben-David,
David Mattson,
Kilian Salerno,
Usha Malhotra,
Kazunori Kanehira,
James Gan,
Steven N. Hochwald
Publication year - 2015
Publication title -
jama surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.757
H-Index - 176
eISSN - 2168-6262
pISSN - 2168-6254
DOI - 10.1001/jamasurg.2014.3867
Subject(s) - medicine , chemoradiotherapy , esophageal cancer , esophagectomy , neoadjuvant therapy , positron emission tomography , standardized uptake value , adenocarcinoma , radiology , retrospective cohort study , radiation therapy , nuclear medicine , cancer , breast cancer
Predicting complete pathologic response (CPR) preoperatively can significantly affect surgical decision making. There are conflicting data regarding positron emission tomography computed tomography (PET CT) characteristics and the ability of PET CT to predict pathologic response following neoadjuvant chemoradiotherapy in esophageal adenocarcinoma because most existing studies that include squamous histology have limited numbers and use nonstandardized PET CT imaging.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom